Impact and role of pulmonary embolism response teams in venous thromboembolism associated with COVID-19

J Investig Med. 2021 Aug;69(6):1153-1155. doi: 10.1136/jim-2021-001856. Epub 2021 May 26.

Abstract

Venous thromboembolism associated with COVID-19, particularly acute pulmonary embolism, may represent a challenging and complex clinical scenario. The benefits of having a multidisciplinary pulmonary embolism response team (PERT) can be important during such a pandemic. The aim of PERT in the care of such patients is to provide fast, appropriate, multidisciplinary, team-based approach, with the common goal to tailor the best therapeutic decision making, prioritizing always optimal patient care, especially given lack of evidence-based clinical practice guidelines in the setting of COVID-19, which potentially confers a significant prothrombotic state. Herein, we would like to briefly emphasize the importance and potential critical role of PERT in the care of patients in which these two devastating illnesses are present together.

Keywords: COVID-19; pulmonary embolism; thromboembolism; thrombosis; vascular diseases.

Publication types

  • Review

MeSH terms

  • Acute Disease
  • Anticoagulants / therapeutic use
  • COVID-19 / complications
  • COVID-19 / therapy*
  • Cardiology / organization & administration
  • Decision Making
  • Evidence-Based Medicine
  • Humans
  • Interdisciplinary Communication
  • Practice Guidelines as Topic
  • Pulmonary Embolism / complications
  • Pulmonary Embolism / therapy*
  • Pulmonary Medicine / organization & administration
  • Quality of Life
  • SARS-CoV-2
  • Thromboembolism / complications
  • Thromboembolism / therapy*
  • Thrombolytic Therapy
  • Treatment Outcome
  • Venous Thromboembolism / complications
  • Venous Thromboembolism / therapy*

Substances

  • Anticoagulants